1. A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma. (April 2021) Authors: Yang, Eddy S.; Deutsch, Eric; Mehmet, Altan; Fayette, Jerome; TAO, Yungan; Nabell, Lisle; Spencer, Sharon A.; Wang, Xuejing A.; Spoljoric, Elizabeth A.; Zhang, Wei; Hynes, Scott M.; Decker, Rodney L.; Lin, Aimee K. Bence; William, William N. Journal: Radiotherapy and oncology Issue: Volume 157(2021) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer. (17th August 2022) Authors: Gbolahan, Olumide; Hashemi‐Sadraei, Neda; Yash, Suri; Williams, Grant; Ramachandran, Rekha; Kim, Young‐il; Paluri, Ravikumar; Outlaw, Darryl; El‐Rayes, Bassel; Nabell, Lisle Journal: Cancer medicine Issue: Volume 12:Number 3(2023) Page Start: 3488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single‐center experience and literature review. Issue 4 (21st May 2014) Authors: Paluri, Ravi; Nabell, Lisle; Borak, Samuel; Peker, Deniz Journal: Hematological oncology Issue: Volume 33:Issue 4(2015:Dec.) Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study. Issue 12 (December 2022) Authors: Meric-Bernstam, Funda; Beeram, Muralidhar; Hamilton, Erika; Oh, Do-Youn; Hanna, Diana L; Kang, Yoon-Koo; Elimova, Elena; Chaves, Jorge; Goodwin, Rachel; Lee, Jeeyun; Nabell, Lisle; Rha, Sun Young; Mayordomo, Jose; El-Khoueiry, Anthony; Pant, Shubham; Raghav, Kanwal; Kim, Jin Won; Patnaik, Amita; ... Journal: Lancet oncology Issue: Volume 23:Issue 12(2022) Page Start: 1558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗